Earnings History Data for Landos Biopharma, Inc. (LABP) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Landos Biopharma, Inc.
Landos Biopharma Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of oral therapeutics for patients with autoimmune diseases. Landos Biopharma Inc. is based in BLACKSBURG, Va.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21-03-2024 | PM | LABP | Landos Biopharma | 22.00 | -0.99 | -0.91 | 0.00 | Landos Biopharma reports Q4 results [3/21/2024 10:34 AM] |
7.45 | 0.46 (6.58%) |
0.0 | 0.0 (0.00%) |
2.33 - 7.90 | 10,155 | 10,000 | 0 | ||
| 12-05-2023 | PM | LABP | Landos Biopharma, Inc. | 8.89 | -0.09 | -0.10 | -0.37 | Landos Biopharma GAAP EPS of -$0.09 beats by $0.01 [5/12/2023 9:04 AM] |
0.2977 | 0.0 (1.02%) |
0.29 | -0.01 (-3.01%) |
0.21 - 1.37 | 187,304 | 30,000 | 204 | ||
| 10-11-2022 | PM | LABP | Landos Biopharma | 10.00 | -0.20 | -0.29 | 0.00 | Landos Biopharma GAAP EPS of -$0.20 beats by $0.08 [11/10/2022 9:16 AM] |
0.27 | 0.04 (17.39%) |
0.23 | 0.0 (0.00%) |
0.21 - 15.00 | 313,879 | 1,050,000 | 100 | ||
| 12-05-2022 | AH | 4:45 PM ET (May 12) |
LABP | Landos Biopharma | 28.00 | -0.37 | -0.37 | 0.00 | Landos Biopharma GAAP EPS of -$0.37 [5/12/2022 5:06 PM] |
0.6381 | -0.03 (-4.58%) |
0.73 | 0.06 (9.71%) |
0.61 - 16.17 | 149,141 | 170,000 | 2,780 | |
|
||||||||||||||||||
| 24-03-2022 | AH | LABP | Landos Biopharma | 69.00 | -0.52 | -0.30 | 0.00 | Landos Biopharma GAAP EPS of -$1.02 [3/24/2022 5:12 PM] |
1.78 | -0.02 (-1.11%) |
1.85 | 0.05 (2.78%) |
1.41 - 16.17 | 88,843 | 96,600 | 1,421 | ||
| 15-11-2021 | PM | 7:30 AM ET (Nov 15) |
LABP | Landos Biopharma | 601.00 | -0.32 | -0.44 | 0.00 | Landos Biopharma EPS beats by $0.11 [11/15/2021 7:34 AM] |
13.82 | -1.16 (-7.74%) |
15.01 | 0.03 (0.20%) |
8.82 - 16.99 | 104,859 | 80,000 | 500 | |
| 29-07-2021 | PM | 7:15 AM ET (Jul 29) |
LABP | Landos Biopharma, Inc. | 437.00 | 0.12 | -0.14 | 0.00 | Landos Biopharma reports Q2 results [7/29/2021 9:34 AM] |
11.39 | -0.17 (-1.47%) |
11.56 | 0.0 (0.00%) |
8.82 - 16.99 | 61,379 | 50,000 | 1,196 | |